Filing Details
- Accession Number:
- 0001209191-17-027736
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-04-20 16:55:49
- Reporting Period:
- 2017-04-19
- Filing Date:
- 2017-04-20
- Accepted Time:
- 2017-04-20 16:55:49
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1337553 | Aerie Pharmaceuticals Inc | AERI | Biological Products, (No Disgnostic Substances) (2836) | 203109565 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1589991 | D. Gerald Cagle | C/O Aerie Pharmaceuticals, Inc. 2030 Main Street, Suite 1500 Irvine CA 92614 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2017-04-19 | 1,000 | $41.60 | 10,900 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-04-19 | 1,000 | $41.80 | 11,900 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct |